Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02155712 · ClinicalTrials.gov registry record · NA

Triathlon Tritanium Knee Outcomes Study

A NA study, sponsored by Stryker Orthopaedics.

Terminated
Registry status
NA
Development phase
680
Enrollment target

NCT02155712: Clinical Trial NA study, sponsored by Stryker Orthopaedics.

NCT02155712 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 680 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02155712, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.

TERMINATED
Registry status
NA
Development phase
680 participants
Enrollment target

Study Summary

The success of the Triathlon Tritanium Knee will be determined by comparing the rate of absence of revision for aseptic loosening of the tibial baseplate at 2 years with the rates reported in the literature.

Primary Outcome

Success is defined as freedom from Triathlon Tritanium Tibial Baseplate revision for aseptic loosening.

Interventions

  • DEVICE Triathlon Tritanium Knee
  • DEVICE Triathlon Knee

Trial Details

FieldValue
Enrollment Target 680 participants
Start Date 2014-10
Est. Completion 2023-03-11
Phase NA
Stryker Orthopaedics

27 total trials

Why NCT02155712 stopped before completion

NCT02155712 is an interventional study that assigns participants to a tested intervention. The registered 680 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (52% lower).

The record links to 0 conditions, and to 2 interventions - of which Triathlon Tritanium Knee is the first listed.

NCT02155712 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02155712 about?

NCT02155712 is a clinical study titled "Triathlon Tritanium Knee Outcomes Study". The success of the Triathlon Tritanium Knee will be determined by comparing the rate of absence of revision for aseptic loosening of the tibial baseplate at 2 years with the rates reported in the literature.

What is the current status of trial NCT02155712?

This trial is currently terminated. It is a NA study. The enrollment target is 680 participants. The study started on 2014-10. Estimated completion is 2023-03-11.

What interventions are being tested in trial NCT02155712?

The interventions under investigation include: Triathlon Tritanium Knee (DEVICE), Triathlon Knee (DEVICE).

Who is sponsoring clinical trial NCT02155712?

This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02155712's enrollment target sits among peer trials

680 151st of 2000 higher than 1,850 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03501706 · 680 participants · NA

    An Assessment of Cognitive Improvement Training Among Mid-life Individuals

  • NCT05626452 · 680 participants · NA

    PrEP Optimization Among Women to Enhance Retention and Uptake

  • NCT05753748 · 680 participants · NA

    Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

  • NCT05952141 · 680 participants · NA

    Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02155712, the US trial registry maintained by the National Library of Medicine. NCT02155712 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.